[Systemic corticosteroids in inflammatory bowel disease: are they really effective. What is their real toxicity?].
Bastida
Guillermo
G
Unidad de Gastroenterología, Servicio de Medicina Digestiva, Hospital Universitario La Fe, Valencia, España. guille.bastida@gmail.com
Muñoz
Fernando
F
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001847:Bone Diseases / Q000139:chemically induced; D002386:Cataract / Q000139:chemically induced; D018849:Controlled Clinical Trials as Topic / Q000706:statistics & numerical data; D018450:Disease Progression; D004198:Disease Susceptibility; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D044882:Glucose Metabolism Disorders / Q000139:chemically induced; D006801:Humans; D007239:Infections / Q000209:etiology; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D015201:Meta-Analysis as Topic; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012074:Remission Induction
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents